Intracranial Hemorrhage Risk of Intensive Statin in Acute Ischemic Stroke With Cerebral Microbleeds
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 344 participants.
Also called NCT05589454
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 344 participants
- Registry
-
NCT05589454
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT05589454. Randomized; no masking; primary purpose prevention. Start 2023-01 (anticipated); primary completion 2026-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Intracranial Hemorrhage Risk of Intensive Statin in Acute Ischemic Stroke With Cerebral Microbleeds
- Condition
- Acute Ischemic Stroke
- Condition
- Cerebral Microbleeds
- Intervention (Drug)
- Atorvastatin Calcium tablets 80mg
- Intervention (Drug)
- Atorvastatin Calcium tablets 20mg
- Lead sponsor
- Sichuan Provincial People's Hospital
- Collaborator
- Science and Technology Department of Sichuan Province
Record details
- Record id
cardio:ct-nct05589454- Content hash
757b9b3396806ed51ca3a7b222e15f682c97990decbfee1788a1c714ad794abe